Quick Answer
GoodRx Holdings, Inc. reported Stockholders Equity of $616.26 million for fiscal year 2025.
GoodRx Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $616.26M | -15.0% |
| 2024 | $724.66M | -4.9% |
| 2023 | $761.96M | -6.5% |
| 2022 | $814.83M | -2.0% |
| 2021 | $831.68M | +16.9% |
| 2020 | $711.36M | +165.4% |
| 2019 | -$1.09B | +6.4% |
| 2018 | -$1.16B | -3560.8% |
| 2017 | -$31.75M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $600.71M | -13.7% | -6.6% |
| June 30, 2025 | $643.03M | -3.9% | -1.7% |
| March 31, 2025 | $654.35M | +3.7% | -9.7% |
| December 31, 2024 | $724.66M | -4.9% | +4.1% |
| September 30, 2024 | $696.43M | -21.0% | +4.0% |
| June 30, 2024 | $669.40M | -25.2% | +6.1% |
| March 31, 2024 | $631.07M | -23.7% | -17.2% |
| December 31, 2023 | $761.96M | -6.5% | -13.5% |
- GoodRx Holdings, Inc. showed a decrease of -15.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, GoodRx Holdings, Inc.’s stockholders equity has grown by 2040.8% (from -$31.75 million to $616.26 million).
- The most recent figure is from GoodRx Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: